Article
Cystic Fibrosis: A Novel Pharmacologic Approach to Cystic Fibrosis Transmembrane Regulator Modulation Therapy.
The Journal of the American Osteopathic Association - 1 Sept 2015
Virant-Young Deborah, Thomas Justin, Woiderski Sarah, Powers Michelle, Carlier Joseph, McCarty James, Kupchick Tyler, Larder Anthony
Abstract excerpt
Therapy for cystic fibrosis (CF) has progressed during the past several decades. Much of this progress is because of advances in genetic testing to precisely identify the underlying cause of CF transmembrane regulator (CFTR) dysfunction. However, with more than 1900 mutations that can produce a faulty CFTR, the management of CF can remain a challenge. Several innovative drugs recently approved by the Food and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.